149 related articles for article (PubMed ID: 25640043)
1. [The Use of anti-VEGF preparations and PDT in the treatment of retinal juxtapapillary hemangioma - a case report].
Matušková V; Vysloužilová D
Cesk Slov Oftalmol; 2014 Oct; 70(5):196-200. PubMed ID: 25640043
[TBL] [Abstract][Full Text] [Related]
2. Combined intravitreal anti-vascular endothelial growth factor (Avastin) and photodynamic therapy to treat retinal juxtapapillary capillary haemangioma.
Mennel S; Meyer CH; Callizo J
Acta Ophthalmol; 2010 Aug; 88(5):610-3. PubMed ID: 19222401
[TBL] [Abstract][Full Text] [Related]
3. The follow-up observation on the therapeutic effect of photodynamic therapy for the juxtapapillary retinal capillary hemangioma: a case report.
Tong B; Xiao J; Su G
BMC Ophthalmol; 2018 Oct; 18(1):277. PubMed ID: 30367611
[TBL] [Abstract][Full Text] [Related]
4. Retinal capillary hemangioma treated with verteporfin photodynamic therapy and intravitreal triamcinolone acetonide.
Suh SC; Jin SY; Bae SH; Kim CG; Kim JW
Korean J Ophthalmol; 2007 Sep; 21(3):178-84. PubMed ID: 17804927
[TBL] [Abstract][Full Text] [Related]
5. Intravitreal bevacizumab for retinal capillary hemangioblastoma: A case series and literature review.
Slim E; Antoun J; Kourie HR; Schakkal A; Cherfan G
Can J Ophthalmol; 2014 Oct; 49(5):450-7. PubMed ID: 25284102
[TBL] [Abstract][Full Text] [Related]
6. Single-session photodynamic therapy combined with intravitreal bevacizumab for retinal angiomatous proliferation.
Lo Giudice G; Gismondi M; De Belvis V; Cian R; Tavolato M; Galan A
Retina; 2009; 29(7):949-55. PubMed ID: 19584653
[TBL] [Abstract][Full Text] [Related]
7. Intravitreal anti-vascular endothelial growth factor therapy versus photodynamic therapy for idiopathic choroidal neovascularization.
Kang HM; Koh HJ
Am J Ophthalmol; 2013 Apr; 155(4):713-9, 719.e1. PubMed ID: 23219069
[TBL] [Abstract][Full Text] [Related]
8. Comparison between anti-vascular endothelial growth factor therapy and photodynamic therapy for myopic choroidal neovascularization.
Matsuo M; Honda S; Matsumiya W; Kusuhara S; Tsukahara Y; Negi A
Eur J Ophthalmol; 2012; 22(2):210-5. PubMed ID: 21534251
[TBL] [Abstract][Full Text] [Related]
9. Intravitreal bevacizumab (Avastin) in combination with verteporfin photodynamic therapy for choroidal neovascularization associated with age-related macular degeneration (IBeVe Study).
Costa RA; Jorge R; Calucci D; Melo LA; Cardillo JA; Scott IU
Graefes Arch Clin Exp Ophthalmol; 2007 Sep; 245(9):1273-80. PubMed ID: 17333238
[TBL] [Abstract][Full Text] [Related]
10. Verteporfin photodynamic therapy of six eyes with retinal capillary haemangioma.
Sachdeva R; Dadgostar H; Kaiser PK; Sears JE; Singh AD
Acta Ophthalmol; 2010 Dec; 88(8):e334-40. PubMed ID: 20946329
[TBL] [Abstract][Full Text] [Related]
11. Verteporfin therapy and intravitreal bevacizumab combined and alone in choroidal neovascularization due to age-related macular degeneration.
Lazic R; Gabric N
Ophthalmology; 2007 Jun; 114(6):1179-85. PubMed ID: 17544776
[TBL] [Abstract][Full Text] [Related]
12. Combined intravitreal bevacizumab and photodynamic therapy for retinal angiomatous proliferation.
Saito M; Shiragami C; Shiraga F; Nagayama D; Iida T
Am J Ophthalmol; 2008 Dec; 146(6):935-41.e1. PubMed ID: 18723139
[TBL] [Abstract][Full Text] [Related]
13. Photodynamic therapy for choroidal hemangioma unresponsive to ranibizumab.
Chan LW; Hsieh YT
Optom Vis Sci; 2014 Sep; 91(9):e226-9. PubMed ID: 25036544
[TBL] [Abstract][Full Text] [Related]
14. Ruthenium-106 brachytherapy and intravitreal bevacizumab for retinal capillary hemangioma.
Russo V; Stella A; Barone A; Scott IU; Noci ND
Int Ophthalmol; 2012 Feb; 32(1):71-5. PubMed ID: 22271068
[TBL] [Abstract][Full Text] [Related]
15. Laser photocoagulation, photodynamic therapy, and intravitreal bevacizumab for the treatment of juxtafoveal choroidal neovascularization secondary to pathologic myopia.
Parodi MB; Iacono P; Papayannis A; Sheth S; Bandello F
Arch Ophthalmol; 2010 Apr; 128(4):437-42. PubMed ID: 20142520
[TBL] [Abstract][Full Text] [Related]
16. Intravitreal bevacizumab vs verteporfin photodynamic therapy for neovascular age-related macular degeneration.
Bashshur ZF; Schakal A; Hamam RN; El Haibi CP; Jaafar RF; Noureddin BN
Arch Ophthalmol; 2007 Oct; 125(10):1357-61. PubMed ID: 17923543
[TBL] [Abstract][Full Text] [Related]
17. Combination treatment of photodynamic therapy with verteporfin and intravitreal ranibizumab in patients with retinal angiomatous proliferation.
Seidel G; Werner C; Weger M; Steinbrugger I; Haas A
Acta Ophthalmol; 2013 Sep; 91(6):e482-5. PubMed ID: 23786546
[TBL] [Abstract][Full Text] [Related]
18. Photodynamic therapy for retinal capillary hemangioma.
Papastefanou VP; Pilli S; Stinghe A; Lotery AJ; Cohen VM
Eye (Lond); 2013 Mar; 27(3):438-42. PubMed ID: 23288135
[TBL] [Abstract][Full Text] [Related]
19. Bevacizumab vs photodynamic therapy for choroidal neovascularization in multifocal choroiditis.
Parodi MB; Iacono P; Kontadakis DS; Zucchiatti I; Cascavilla ML; Bandello F
Arch Ophthalmol; 2010 Sep; 128(9):1100-3. PubMed ID: 20837791
[TBL] [Abstract][Full Text] [Related]
20. Retinal capillary hemangioma treated with verteporfin photodynamic therapy.
Atebara NH
Am J Ophthalmol; 2002 Nov; 134(5):788-90. PubMed ID: 12429270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
